Presentation is loading. Please wait.

Presentation is loading. Please wait.

Menopausal effects on presentation, treatment, and survival of women with non–small cell lung cancer  Kimberly A Moore, MD, Carlos M Mery, MD, MPH, Michael.

Published byMervin Campbell Modified over 5 years ago

Similar presentations

Presentation on theme: "Menopausal effects on presentation, treatment, and survival of women with non–small cell lung cancer  Kimberly A Moore, MD, Carlos M Mery, MD, MPH, Michael."— Presentation transcript:

1 Menopausal effects on presentation, treatment, and survival of women with non–small cell lung cancer 
Kimberly A Moore, MD, Carlos M Mery, MD, MPH, Michael T Jaklitsch, MD, Anastasia P. Estocin, MPH, Raphael Bueno, MD, Scott J Swanson, MD, David J Sugarbaker, MD, Jeanne M Lukanich, MD  The Annals of Thoracic Surgery  Volume 76, Issue 6, Pages (December 2003) DOI: /S (03)

2 Fig 1 Kaplan–Meier curves for lung cancer-related survival (months) in premenopausal (—) and postmenopausal ( · · · · · ) women with non–small cell lung carcinoma in all stages (A) and stages I and II (B). The Annals of Thoracic Surgery  , DOI: ( /S (03) )

3 Fig 2 (A) Kaplan–Meier curves for lung cancer-related survival (months) in (A) premenopausal women ( · · · · · ) and younger men (—) and (B) postmenopausal women ( · · · · · ) and older men (—) with all stages of non–small cell lung carcinoma. Results indicate a survival advantage for women when compared with their male counterparts. The Annals of Thoracic Surgery  , DOI: ( /S (03) )

Download ppt "Menopausal effects on presentation, treatment, and survival of women with non–small cell lung cancer  Kimberly A Moore, MD, Carlos M Mery, MD, MPH, Michael."

Similar presentations

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment  William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment  William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.
Elizabeth A. David, MD, David T

Elizabeth A. David, MD, David T
Gender differences in non–small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002  Antonio L Visbal, MD, Brent.

Gender differences in non–small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002  Antonio L Visbal, MD, Brent.
Thomas J. Birdas, MD, Richard P. M

Thomas J. Birdas, MD, Richard P. M
Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L

Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L
Relationship between margin distance and local recurrence among patients undergoing wedge resection for small (≤2 cm) non–small cell lung cancer  Kamran.

Relationship between margin distance and local recurrence among patients undergoing wedge resection for small (≤2 cm) non–small cell lung cancer  Kamran.
Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A

Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A
Malignant minor pleural effusion detected on thoracotomy for patients with non–small cell lung cancer: is tumor resection beneficial for prognosis?  Noriyoshi.

Malignant minor pleural effusion detected on thoracotomy for patients with non–small cell lung cancer: is tumor resection beneficial for prognosis?  Noriyoshi.
Quality of life after tailored combined surgery for stage I non–small-cell lung cancer and severe emphysema  Eugenio Pompeo, MD, Enrico De Dominicis,

Quality of life after tailored combined surgery for stage I non–small-cell lung cancer and severe emphysema  Eugenio Pompeo, MD, Enrico De Dominicis,
Joshua E. Rosen, BASc, Hari B

Joshua E. Rosen, BASc, Hari B
Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer

Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer
Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis

Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis
Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.

Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.
Lung cancer staging and treatment in multidisciplinary trials: cancer and leukemia group B cooperative group approach1  Mark J Krasna, MD, Carolyn E Reed,

Lung cancer staging and treatment in multidisciplinary trials: cancer and leukemia group B cooperative group approach1  Mark J Krasna, MD, Carolyn E Reed,
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer  José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,

Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer  José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,
Lung Cancer Staging: A Case for a New T Definition

Lung Cancer Staging: A Case for a New T Definition
Philip A. Linden, MD, Richard J. Gilbert, MD, Beow Y

Philip A. Linden, MD, Richard J. Gilbert, MD, Beow Y
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
Esophageal Resection for Cancer of the Esophagus: Long-Term Function and Quality of Life  Allison J McLarty, MD, Claude Deschamps, MD, Victor F Trastek,

Esophageal Resection for Cancer of the Esophagus: Long-Term Function and Quality of Life  Allison J McLarty, MD, Claude Deschamps, MD, Victor F Trastek,

Similar presentations

Ads by Google